Your browser doesn't support javascript.
loading
Real-world efficacy and safety of dolutegravir plus lamivudine versus tenofovir plus lamivudine and efavirenz in ART-naïve HIV-1-infected adults.
Li, Jin; Chen, Dabiao; Wen, Zhiwei; Du, Yanzhang; Huang, Zhanlian; Zhong, Huijun; Wang, Yanhao; Yin, Sichun.
Afiliação
  • Li J; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, China.
  • Chen D; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Wen Z; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, China.
  • Du Y; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, China.
  • Huang Z; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Zhong H; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, China.
  • Wang Y; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, China.
  • Yin S; Department of Infectious Diseases, The Ninth People's Hospital of Dongguan, Dongguan, China.
Medicine (Baltimore) ; 101(42): e31100, 2022 Oct 21.
Article em En | MEDLINE | ID: mdl-36281149

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies Limite: Adult / Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Observational_studies Limite: Adult / Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China